X0704 D/A LIVE 0001066833 Euthymics Bioscience Inc 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 215-630-7651 DELAWARE None DOV PHARMACEUTICAL INC Corporation true Anthony A. McKinney 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Franklin P. Bymaster 8545 N. Country Road 650 East Brownsburg IN INDIANA 46112 Executive Officer Campbell Murray Novartis BioVentures Ltd. Five Cambridge Center, Suite 603 Cambridge MA MASSACHUSETTS 02142 Director Frank Gentile H&Q Healthcare Investors 2 Liberty Square, 9th Floor Boston MA MASSACHUSETTS 02109 Director Andrew Baker GBS Venture Partners Limited Level 5, 71 Collins Street Melbourne VIC C3 AUSTRALIA 3000 Director Paul Weiss Venture Investors Early Stage Fund IV 505 South Rosa Road, Suite 201 Madison WI WISCONSIN 53719 Director Timothy J. Barberich 48 Elm Street Concord MA MASSACHUSETTS 01742 Director Pierre Tran 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Thomas A. Shea 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Other Technology No Revenues 06 true 0001140361-11-017254 2010-07-20 true true true The first tranche of the Series A Preferred Stock transaction closed contemporaneously with the closing of the merger of Euthymics Bioscience, Inc. and DOV Pharmaceutical, Inc. 28895 28008945 24299848 3709097 The offering will close in 5 separate tranches if certain milestones are met. Tranche 1 ($5,164,326) closed 7/20/10, tranche 2 ($15,208,325) closed 12/3/12, tranche 3 ($2,000,000) closed 3/8/11, & tranche 4 ($1,927,197) closed 3/2/12. false 7 0 0 943000 true Includes legal fees paid to a law firm affiliated with an officer of the Company and one-year's worth of salary for 2 of the Company's executive officers. false Euthymics Bioscience Inc Douglas A. Branch Douglas A. Branch Secretary 2012-03-16